by Women’s health technology products such as female urination devices aim to offer convenience and discretion to women facing health issues like urinary incontinence. Female urination devices allow women to urinate in a standing position and maintain personal hygiene. The global female urination devices market size was valued at US$ 8.37 Billion in 2024 and is estimated to reach US$ 11.40 Billion by 2031, registering a CAGR of 8.8% over the forecast period. As per statistics, one in three women suffers from urinary incontinence globally, with prevalence being higher among older women. Such growing prevalence of associated health conditions is driving awareness and demand for assistive devices.
The global Female Urination Devices Market is estimated to be valued at US$ 11.40 Billion in 2031 and is expected to exhibit a CAGR of 8.8% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Some of the key trends in the Global Female Urination Devices Market Size include novel product launches with improved design and features. For instance, products are being designed for safe and convenient usage during outdoor activities or during traveling. Waterless devices are gaining popularity owing to their eco-friendly nature. Increasing investments by companies in R&D of user-friendly products are expected to support market growth over the forecast period. Further, rising awareness through social media campaigns and online reviews is positively impacting adoption of assistive devices for urinary incontinence.
Porter’s Analysis
Threat of new entrants: Low capital requirement and availability of private label products may attract new players but established brands and regulations prevent easy entry.
Bargaining power of buyers: Buyers have high bargaining power due to availability of substitutes and undifferentiated products. Generic female urination devices are easily substitutable.
Bargaining power of suppliers: Major suppliers have bargaining power due to differentiated and patented products along with established supply chains. Suppliers can threaten forward integration.
Threat of new substitutes: Threat of new substitutes is moderate as traditional methods act as close substitutes. However, innovation may lead to new easy to use devices.
Competitive rivalry: Competition is high among established brands. Players compete based on pricing, branding and innovation to sustain in the crowded market.
Key Takeaways
The global female urination devices market is expected to witness high growth.
Regional analysis: North America accounts for the largest share of the global female urination devices market due to supportive government programs. However, Asia Pacific is poised to grow at a highest CAGR during the forecast period supported by increasing awareness and accessibility of women health products in populous nations like China and India.
Key players: Key players operating in the global Female Urination Devices market are Apple Inc., Fitbit, Inc., Dexcom, Inc., Medtronic plc, Omada Health, Inc., Propeller Health, AliveCor, Inc., WellDoc, Inc., Noom, Inc., Livongo Health, HealthMine, Inc., Epic Systems Corporation, Allscripts Healthcare Solutions, Cerner Corporation, and Athenahealth, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
